Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
82 Cards in this Set
- Front
- Back
incidence is ___/___
|
new cases
population at risk |
|
prevalence in terms of incidence
|
incidence x disease duration
(approximately) |
|
prevalence > incidence for ___
prevalence = incidence for ___ |
chronic diseases
acute diseases |
|
statistic for case-control studies
|
odds ratio
|
|
odds ratio definition: ___/___
|
odds of disease in exposed group
odds of disease in unexposed group |
|
odds ratio formula
|
OR = (ad/bc)
where (a,b) are exposed with + without disease (c,d) are unexposed with + without disease |
|
statistic for cohort studies
|
relative risk
|
|
relative risk definition: ___/___
|
probability of disease in exposed group
probability of disease in unexposed group |
|
relative risk formula
|
RR = [a/(a + b)] / [c/(c + d)]
where (a,b) are exposed with + without disease (c,d) are unexposed with + without disease |
|
number needed to treat
|
NNT=1/ARR
|
|
number needed to harm
|
NNH = 1/attributable risk
|
|
type I error is aka ___
it means ___ |
alpha
false positive |
|
type II error is aka ___
it means ___ |
beta
false negative |
|
phase 1 studies have ___ n who are sick/healthy
it checks ___ (2) |
small
healthy safety pharmacokinetics |
|
phase 2 studies have ___ n who are sick/healthy
it checks ___ (3) |
small
sick efficacy dosing SEs |
|
phase 3 studies have ___ n who are sick/healthy
it checks ___ |
large
sick how new drug compares to standard tx |
|
statistical power definition
|
probability of true positive (correct rejection of H_0)
|
|
formula for statistical power
|
1-beta
|
|
3 determinants of statistical power
|
# of endpoints experienced by population
difference in compliance between groups size of expected effect |
|
% of population within 1 SD of mean
|
68
|
|
% of population within 2 SD of mean
|
95
|
|
% of population within 3 SD of mean
|
99.7
|
|
formula for SEM
|
SD/sqrt(n)
|
|
use chi-square to compare ___ or more ___s
|
2
percentages or proportions |
|
coefficient of correlation ranges from ___ to ___
|
-1
1 |
|
1' prevention does ___
|
prevent disease
|
|
2' prevention does ___
|
early detection
|
|
3' prevention does ___
|
reduce disability from disease
|
|
13 diseases reportable in all states
|
Hep A-C
Salmonella Shigella Syphilis Measles Mumps AIDS Rubella TB Chickenpox Gonorrhea |
|
3 parts of informed consent
|
discussion of pertinent information
patient's agreement freedom from coercion |
|
4 exceptions to informed consent
|
incompetence
emergency (implied consent) when informing would harm patient (therapeutic privilege) patient waives his/her right |
|
5 criteria for acceptable patient choice
|
communicated by patient
patient is informed decision is stable decision is consistent with patient's values decision is not result of delusions/hallucinations |
|
T/F: patient's family can demand that doctor withhold information from patient
|
false
|
|
durable power of attorney means ___
|
patient appoints someone to make decisions for him/her
|
|
T/F: patient may revoke power of attorney from the appointed person
|
true
|
|
3 conditions for violating confidentiality
|
likely harm to self or others
the harm is preventable no other way to warn those in danger |
|
4 conditions for malpractice
|
physician had a duty
the duty was breached (dereliction) patient was harmed (damage) the breach of duty caused the harm (direct) |
|
T/F: family members are entitled to information about patient's case
|
false: need patient's consent
|
|
T/F: it's ok to tell child about his illness
|
false: need to go through parents
|
|
T/F: it's ok to give condoms + contraception without consulting parents
|
true
|
|
T/F: it's ok for doctor to receive money from drug company for referrals to drug trial
|
false: can't ever get drug money
|
|
5 parts of APGAR score
|
Appearance
Pulse Grimace Activity Respiration |
|
give 2 APGAR appearance points for ___, 1 for ___ and 0 for ___
|
all pink
trunk pink blue |
|
give 2 APGAR pulse points for ___, 1 for ___ and 0 for ___
|
>100
<100 none |
|
give 2 APGAR grimace points for ___, 1 for ___ and 0 for ___
|
grimace + cough
grimace none |
|
give 2 APGAR activity points for ___, 1 for ___ and 0 for ___
|
active
some limp |
|
give 2 APGAR respiration points for ___, 1 for ___ and 0 for ___
|
regular
irregular none |
|
low birth weight definition
|
<2500g
|
|
social smile appears at ___
|
3 mo
|
|
stranger anxiety appears at ___
|
7--9 mo
|
|
Moro reflex is sequence of ___ (3) on ___
it disappears at ___ |
arm abduction
arm adduction crying pull/release from supine position 3 mo |
|
plantar extensor reflex disappears at ___
|
15 mo
|
|
for first 3 years, # of blocks stacked equals ___
|
years old x 3
|
|
2 years old creates sentences ___ words long
|
2
|
|
object permanence is achieved by age ___
|
2
|
|
according to Piaget, logical thinking starts at ___, during the ___ stage
but abstract thinking not till ___, during the ___ stage |
7
concrete operational 12 formal operational |
|
4 sleep changes in elderly
|
increased latency
reduced REM sleep reduced slow-wave sleep increased awakenings |
|
normal BMI is ___
obese is ___ morbidly obese is ___ |
18.5--24.9
>30 >40 |
|
EEG rhythm during normal awake state
this has ___ frequency and ___ amplitude |
beta
high low |
|
EEG rhythm during light sleep (stage 1)
you spend ___% of sleep in this stage |
theta
5 |
|
EEG rhythm during intermediate sleep (stage 2)
you spend ___% of sleep in this stage |
sleep spindles + K complexes
45 |
|
EEG rhythm during deep sleep (stage 3--4)
this has ___ frequency and ___ amplitude you spend ___% of sleep in this stage |
delta
low high 25 |
|
EEG rhythm during REM sleep
you spend ___% of sleep in this stage |
beta
25 |
|
___ happens in stage 2 sleep
|
bruxism
|
|
___ (3) happens in stage 3--4 sleep
|
sleepwalking
night terrors bedwetting |
|
___ (3) happens during REM sleep
|
dreaming
paralysis erection |
|
brain O2 use is highest during ___ sleep
|
REM
|
|
neurotransmitter important in sleep initiation
|
5-HT
|
|
neurotransmitter which promotes REM sleep
neurotransmitter which reduces REM sleep |
ACh
NE |
|
2 drugs which shortens stage 4 sleep
|
BDZ (useful for night terrors, sleepwalking)
imipramine (useful for enuresis) |
|
pulse during REM sleep is ___ (2)
|
fast
variable |
|
BP during REM sleep is ___ (2)
|
high
variable |
|
REM occurs every ___ hours during the night
duration of REM ___s as night goes on |
1.5
increases |
|
narcolepsy is associated with ___ (3)
|
hypnagogic hallucination
hypnapompic hallucination cataplexy |
|
cataplexy is ___ in response to ___
|
loss of muscle tone
emotional stimulus |
|
narcoleptic sleep starts with ___ stage
|
REM
|
|
2 tx for narcolepsy
|
amphetamine
modafinil |
|
melatonin release from ___ is triggered by ___ release from ___
|
pineal
NE HTh SCN |
|
2 main CNS functions of NE
|
stimulant
pain control |
|
elevated synaptic NE causes ___ pain
|
reduced
|
|
most important CNS function of ACh
|
memory
|
|
HAergic cells in CNS are found mainly in ___
3 CNS functions of HA |
HTh
sedation weight control cardiovascular |